MedTrace Logo

Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II

NCT01537302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-03-22

Study results available
· View outcomes & findings →

Summary

Evaluation of the safety and effectiveness of the Ocelot System to provide OCT-assisted orientation while simultaneously crossing totally occluded femoropopliteal arteries.

Conditions

  • Total Atherosclerotic Occlusion of Femoral Artery

Interventions

DEVICE

CTO crossing in femoropopliteal arteries CONNECT II

CTO crossing in femoropopliteal arteries using the Ocelot System

Sponsors & Collaborators

  • Avinger, Inc.

    lead INDUSTRY

Principal Investigators

  • Matthew Selmon, MD · Austin Heart Hospital

  • Arne Schwindt, MD · Muenster Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01537302 on ClinicalTrials.gov